The Budget Impact of Cangrelor in the UK for the Treatment of Out-of-Hospital Cardiac Arrest Patients Who Require Percutaneous Coronary Intervention

The Budget Impact of Cangrelor in the UK for the Treatment of Out-of-Hospital Cardiac Arrest Patients Who Require Percutaneous Coronary Intervention

Bhavik Modi,1 Rob Cain,2 Richard Stork,2 Caroline Barwood,3 Gina Tarpey,2 Alessia Colucciello4 1Cardiac Surgery Department, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK; 2Chiesi Ltd, Manchester, UK; 3FIECON Ltd, London, UK; 4Chiesi Farmaceutici S.p.A., Parma, ItalyC...

Full description

Saved in:
Bibliographic Details
Main Authors: Modi B, Cain R, Stork R, Barwood C, Tarpey G, Colucciello A
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
glycoprotein inhibitor
p2y12 inhibitor
cardiovascular disease
out-of-hospital cardiac arrest
antiplatelet therapy
Online Access:https://www.dovepress.com/the-budget-impact-of-cangrelor-in-the-uk-for-the-treatment-of-out-of-h-peer-reviewed-fulltext-article-CEOR
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items